Stock Events

Haemato 

€15
0
+€0+0% Wednesday 13:44

Statistics

Day High
0
Day Low
0
52W High
28
52W Low
0
Volume
0
Avg. Volume
171
Mkt Cap
-
P/E Ratio
0.04
Dividend Yield
0.27%
Dividend
0.04

Upcoming

17
JUL 25
Dividend Ex
Estimated
 
19
JUL 25
Dividend Payment
Estimated
 
17
JUL 26
Dividend Ex
Estimated
 
19
JUL 26
Dividend Payment
Estimated
 

Dividends

0.27%Dividend Yield
Jul 24
€0.04
Jul 23
€1.2
Jul 22
€1.1
Jul 21
€1
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
-65.8%
1Y Growth
-96.67%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0VZ7.LSE. It's not an investment recommendation.
Alphabet
78096
GOOGL
Apple
67979
AAPL
Microsoft
63406
MSFT
Amazon
59137
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap244.75B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Haemato in the development and marketing of medical products.
Pfizer
PFE
Mkt Cap164.39B
Pfizer is a multinational pharmaceutical corporation that competes with Haemato in the pharmaceuticals market, particularly in the areas of research, development, and distribution of drugs.
Merck
MRK
Mkt Cap300.25B
Merck & Co., Inc. is a leading global biopharmaceutical company that competes with Haemato in the discovery, development, and commercialization of medicines and vaccines.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson is a comprehensive healthcare company that has a strong presence in the pharmaceuticals sector, making it a competitor to Haemato in various therapeutic areas.
GSK
GSK
Mkt Cap89.55B
GlaxoSmithKline is a global healthcare company that engages in the creation and distribution of pharmaceuticals, vaccines, and consumer healthcare products, competing with Haemato.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie is a biopharmaceutical company that develops and markets therapies, directly competing with Haemato in the pharmaceuticals and healthcare market.
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Bristol Myers Squibb is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines, competing with Haemato in several therapeutic areas.
Sanofi
SNY
Mkt Cap141.43B
Sanofi is a global life sciences company that offers a wide range of pharmaceutical products, directly competing with Haemato in the healthcare and pharmaceutical sectors.
Roche
RHHBY
Mkt Cap272.83B
Roche Holding AG is a pioneer in healthcare, focusing on pharmaceuticals and diagnostics, and competes with Haemato in the development and marketing of medical solutions.
Astrazeneca
AZN
Mkt Cap271.67B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Haemato in the discovery and development of prescription medicines.

About

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV/AIDS, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, medical laboratories, and hospitals. The company was founded in 1993 and is headquartered in Schönefeld, Germany.
Show more...
CEO
Employees
147
Country
DE
ISIN
DE000A289VV1

Listings

LSE
GB
0VZ7.LSE
US
HAAGF